Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,399,000 | 1,273,000 | 2,288,000 | 1,106,000 | 2,103,000 |
| Receivables | 4,349,000 | 4,384,000 | 4,129,000 | 4,155,000 | 4,136,000 |
| Inventories | 3,370,000 | 3,308,000 | 3,209,000 | 3,124,000 | 3,005,000 |
| Other current assets | 1,775,000 | 1,549,000 | 1,597,000 | 1,554,000 | 1,381,000 |
| TOTAL | $11,893,000 | $10,514,000 | $11,223,000 | $9,939,000 | $10,625,000 |
| Non-Current Assets | |||||
| PPE Net | 4,749,000 | 4,420,000 | 4,394,000 | 4,192,000 | 4,165,000 |
| Intangibles | 39,728,000 | 39,935,000 | 40,620,000 | 39,725,000 | 40,325,000 |
| Other Non-Current Assets | 2,011,000 | 1,860,000 | 1,733,000 | 1,740,000 | 1,117,000 |
| TOTAL | $46,488,000 | $46,215,000 | $46,747,000 | $45,657,000 | $45,607,000 |
| Total Assets | $58,381,000 | $56,729,000 | $57,970,000 | $55,596,000 | $56,232,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,920,000 | 1,659,000 | 1,391,000 | 1,462,000 | 1,615,000 |
| Accrued Expenses | 1,010,000 | 883,000 | 809,000 | 704,000 | 982,000 |
| Other current liabilities | 916,000 | 943,000 | 1,062,000 | 967,000 | 809,000 |
| TOTAL | $6,197,000 | $5,844,000 | $7,509,000 | $5,898,000 | $6,147,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,076,000 | 16,392,000 | 16,663,000 | 16,812,000 | 17,719,000 |
| Other Non-Current Liabilities | 3,241,000 | 3,137,000 | 3,133,000 | 3,048,000 | 2,515,000 |
| TOTAL | $22,509,000 | $21,530,000 | $21,732,000 | $22,005,000 | $22,499,000 |
| Total Liabilities | $28,706,000 | $27,374,000 | $29,241,000 | $27,903,000 | $28,646,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 398,828 | 400,991 | 400,476 | 399,981 | 399,004 |
| Common Shares | 434,000 | 434,000 | 433,000 | 433,000 | 432,000 |
| Retained earnings | 22,092,000 | 21,165,000 | 20,482,000 | 19,439,000 | 18,696,000 |
| Other shareholders' equity | -2,679,000 | -2,722,000 | -2,630,000 | -2,509,000 | -2,498,000 |
| TOTAL | $29,675,000 | $29,355,000 | $28,729,000 | $27,693,000 | $27,586,000 |
| Total Liabilities And Equity | $58,381,000 | $56,729,000 | $57,970,000 | $55,596,000 | $56,232,000 |